ID   SYN3_HUMAN              Reviewed;         580 AA.
AC   O14994; B1B1F9;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 2.
DT   28-JAN-2026, entry version 205.
DE   RecName: Full=Synapsin-3;
DE   AltName: Full=Synapsin III;
GN   Name=SYN3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9539796; DOI=10.1073/pnas.95.8.4667;
RA   Kao H.-T., Porton B., Czernik A.J., Feng J., Yiu G., Haering M.,
RA   Benfenati F., Greengard P.;
RT   "A third member of the synapsin gene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:4667-4672(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION AT SER-470, AND VARIANT ASN-470.
RX   PubMed=14732590; DOI=10.1016/j.biopsych.2003.07.002;
RA   Porton B., Ferreira A., DeLisi L.E., Kao H.T.;
RT   "A rare polymorphism affects a mitogen-activated protein kinase site in
RT   synapsin III: possible relationship to schizophrenia.";
RL   Biol. Psychiatry 55:118-125(2004).
CC   -!- FUNCTION: May be involved in the regulation of neurotransmitter release
CC       and synaptogenesis.
CC   -!- SUBUNIT: Interacts with CAPON. {ECO:0000250}.
CC   -!- INTERACTION:
CC       O14994; Q92777: SYN2; NbExp=2; IntAct=EBI-36512485, EBI-4286893;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic
CC       vesicle membrane; Peripheral membrane protein; Cytoplasmic side.
CC       Note=Peripheral membrane protein localized to the cytoplasmic surface
CC       of synaptic vesicles.
CC   -!- TISSUE SPECIFICITY: Neuron specific. Detected predominantly in brain.
CC   -!- DOMAIN: The A region binds phospholipids with a preference for
CC       negatively charged species. {ECO:0000250}.
CC   -!- PTM: Phosphorylation at Ser-9 dissociates synapsins from synaptic
CC       vesicles. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Regulated by calcium. Calcium inhibits ATP binding to
CC       the C-domain.
CC   -!- SIMILARITY: Belongs to the synapsin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF046873; AAC15101.1; -; mRNA.
DR   EMBL; CR456589; CAG30475.1; -; mRNA.
DR   EMBL; Z83846; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z71183; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z98256; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z82181; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z82246; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z80902; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60034.1; -; Genomic_DNA.
DR   EMBL; BC075065; AAH75065.1; -; mRNA.
DR   EMBL; BC075066; AAH75066.1; -; mRNA.
DR   EMBL; BC143874; AAI43875.1; -; mRNA.
DR   CCDS; CCDS13908.1; -.
DR   RefSeq; NP_001356836.1; NM_001369907.1.
DR   RefSeq; NP_001356837.1; NM_001369908.1.
DR   RefSeq; NP_003481.3; NM_003490.3.
DR   RefSeq; NP_598344.2; NM_133633.2.
DR   RefSeq; XP_011528707.1; XM_011530405.4.
DR   RefSeq; XP_016884450.1; XM_017028961.3.
DR   RefSeq; XP_016884451.1; XM_017028962.3.
DR   RefSeq; XP_016884452.1; XM_017028963.3.
DR   RefSeq; XP_054181953.1; XM_054325978.1.
DR   RefSeq; XP_054181954.1; XM_054325979.1.
DR   RefSeq; XP_054181955.1; XM_054325980.1.
DR   RefSeq; XP_054181956.1; XM_054325981.1.
DR   PDB; 2P0A; X-ray; 1.90 A; A/B=76-417.
DR   PDBsum; 2P0A; -.
DR   AlphaFoldDB; O14994; -.
DR   SMR; O14994; -.
DR   BioGRID; 113857; 15.
DR   FunCoup; O14994; 141.
DR   IntAct; O14994; 10.
DR   STRING; 9606.ENSP00000351614; -.
DR   GlyGen; O14994; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O14994; -.
DR   PhosphoSitePlus; O14994; -.
DR   BioMuta; SYN3; -.
DR   jPOST; O14994; -.
DR   MassIVE; O14994; -.
DR   PaxDb; 9606-ENSP00000351614; -.
DR   PeptideAtlas; O14994; -.
DR   ProteomicsDB; 48363; -.
DR   ABCD; O14994; 2 sequenced antibodies.
DR   Antibodypedia; 25287; 128 antibodies from 21 providers.
DR   DNASU; 8224; -.
DR   Ensembl; ENST00000358763.7; ENSP00000351614.2; ENSG00000185666.16.
DR   GeneID; 8224; -.
DR   KEGG; hsa:8224; -.
DR   MANE-Select; ENST00000358763.7; ENSP00000351614.2; NM_003490.4; NP_003481.3.
DR   UCSC; uc003amx.4; human.
DR   AGR; HGNC:11496; -.
DR   ClinPGx; PA36278; -.
DR   CTD; 8224; -.
DR   DisGeNET; 8224; -.
DR   GeneCards; SYN3; -.
DR   HGNC; HGNC:11496; SYN3.
DR   HPA; ENSG00000185666; Tissue enhanced (brain).
DR   MalaCards; SYN3; -.
DR   MIM; 602705; gene.
DR   OpenTargets; ENSG00000185666; -.
DR   VEuPathDB; HostDB:ENSG00000185666; -.
DR   eggNOG; KOG3895; Eukaryota.
DR   GeneTree; ENSGT00940000155415; -.
DR   HOGENOM; CLU_010582_3_0_1; -.
DR   InParanoid; O14994; -.
DR   OMA; IGSAYKC; -.
DR   OrthoDB; 10249572at2759; -.
DR   PAN-GO; O14994; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; O14994; -.
DR   PathwayCommons; O14994; -.
DR   Reactome; R-HSA-181429; Serotonin Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-212676; Dopamine Neurotransmitter Release Cycle.
DR   SignaLink; O14994; -.
DR   SIGNOR; O14994; -.
DR   Agora; ENSG00000185666; -.
DR   BioGRID-ORCS; 8224; 10 hits in 1148 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; SYN3; human.
DR   EvolutionaryTrace; O14994; -.
DR   GeneWiki; SYN3; -.
DR   GenomeRNAi; 8224; -.
DR   Pharos; O14994; Tbio.
DR   PRO; PR:O14994; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; O14994; protein.
DR   Bgee; ENSG00000185666; Expressed in primordial germ cell in gonad and 119 other cell types or tissues.
DR   ExpressionAtlas; O14994; baseline and differential.
DR   GO; GO:0098850; C:extrinsic component of synaptic vesicle membrane; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0008021; C:synaptic vesicle; TAS:ProtInc.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0007269; P:neurotransmitter secretion; TAS:ProtInc.
DR   GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0050808; P:synapse organization; IBA:GO_Central.
DR   GO; GO:0097091; P:synaptic vesicle clustering; IBA:GO_Central.
DR   FunFam; 3.30.1490.20:FF:000008; Synapsin I; 1.
DR   FunFam; 3.30.470.20:FF:000042; Synapsin III; 1.
DR   FunFam; 3.40.50.20:FF:000008; Synapsin III; 1.
DR   Gene3D; 3.40.50.20; -; 1.
DR   Gene3D; 3.30.1490.20; ATP-grasp fold, A domain; 1.
DR   Gene3D; 3.30.470.20; ATP-grasp fold, B domain; 1.
DR   InterPro; IPR013815; ATP_grasp_subdomain_1.
DR   InterPro; IPR016185; PreATP-grasp_dom_sf.
DR   InterPro; IPR001359; Synapsin.
DR   InterPro; IPR020898; Synapsin_ATP-bd_dom.
DR   InterPro; IPR019735; Synapsin_CS.
DR   InterPro; IPR019736; Synapsin_P_site.
DR   InterPro; IPR020897; Synapsin_pre-ATP-grasp_dom.
DR   PANTHER; PTHR10841; SYNAPSIN; 1.
DR   PANTHER; PTHR10841:SF27; SYNAPSIN-3; 1.
DR   Pfam; PF02078; Synapsin; 1.
DR   Pfam; PF02750; Synapsin_C; 1.
DR   Pfam; PF10581; Synapsin_N; 1.
DR   PRINTS; PR01368; SYNAPSIN.
DR   SUPFAM; SSF56059; Glutathione synthetase ATP-binding domain-like; 1.
DR   SUPFAM; SSF52440; PreATP-grasp domain; 1.
DR   PROSITE; PS00415; SYNAPSIN_1; 1.
DR   PROSITE; PS00416; SYNAPSIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Calcium; Cytoplasmic vesicle; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Synapse.
FT   CHAIN           1..580
FT                   /note="Synapsin-3"
FT                   /id="PRO_0000183024"
FT   REGION          1..28
FT                   /note="A"
FT   REGION          19..56
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          28..90
FT                   /note="B; linker"
FT   REGION          91..399
FT                   /note="C; actin-binding and synaptic-vesicle binding"
FT   REGION          395..567
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          400..531
FT                   /note="J; Pro-rich linker"
FT   REGION          532..580
FT                   /note="E"
FT   COMPBIAS        30..39
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        47..56
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        419..432
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        441..488
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        489..500
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        537..553
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         9
FT                   /note="Phosphoserine; by PKA and CaMK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8JZP2"
FT   MOD_RES         455
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8JZP2"
FT   MOD_RES         462
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8JZP2"
FT   MOD_RES         470
FT                   /note="Phosphoserine; by CDK1 and MAPK"
FT                   /evidence="ECO:0000269|PubMed:14732590"
FT   MOD_RES         475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8JZP2"
FT   MOD_RES         481
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O70441"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8JZP2"
FT   MOD_RES         541
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8JZP2"
FT   VARIANT         470
FT                   /note="S -> N (in patients affected by schizophrenia;
FT                   dbSNP:rs5998526)"
FT                   /evidence="ECO:0000269|PubMed:14732590"
FT                   /id="VAR_068906"
FT   STRAND          92..97
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   HELIX           104..108
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   TURN            114..116
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          117..124
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   HELIX           126..128
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          129..134
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          139..143
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          160..164
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          168..170
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   HELIX           171..173
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   HELIX           178..186
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          191..193
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   HELIX           195..200
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   HELIX           204..218
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   TURN            220..222
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          229..234
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          241..251
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   TURN            254..257
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          258..261
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   HELIX           264..277
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          281..285
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          289..298
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          301..312
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          318..326
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   HELIX           330..339
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   HELIX           340..344
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          347..356
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   STRAND          361..367
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   HELIX           375..377
FT                   /evidence="ECO:0007829|PDB:2P0A"
FT   HELIX           378..394
FT                   /evidence="ECO:0007829|PDB:2P0A"
SQ   SEQUENCE   580 AA;  63303 MW;  4F61DE236DE8F3C5 CRC64;
     MNFLRRRLSD SSFMANLPNG YMTDLQRPDS STSSPASPAM ERRHPQPLAA SFSSPGSSLF
     SSLSSAMKQA PQATSGLMEP PGPSTPIVQR PRILLVIDDA HTDWSKYFHG KKVNGEIEIR
     VEQAEFSELN LAAYVTGGCM VDMQVVRNGT KVVSRSFKPD FILVRQHAYS MALGEDYRSL
     VIGLQYGGLP AVNSLYSVYN FCSKPWVFSQ LIKIFHSLGP EKFPLVEQTF FPNHKPMVTA
     PHFPVVVKLG HAHAGMGKIK VENQLDFQDI TSVVAMAKTY ATTEAFIDSK YDIRIQKIGS
     NYKAYMRTSI SGNWKANTGS AMLEQVAMTE RYRLWVDSCS EMFGGLDICA VKAVHSKDGR
     DYIIEVMDSS MPLIGEHVEE DRQLMADLVV SKMSQLPMPG GTAPSPLRPW APQIKSAKSP
     GQAQLGPQLG QPQPRPPPQG GPRQAQSPQP QRSGSPSQQR LSPQGQQPLS PQSGSPQQQR
     SPGSPQLSRA SSGSSPNQAS KPGATLASQP RPPVQGRSTS QQGEESKKPA PPHPHLNKSQ
     SLTNSLSTSD TSQRGTPSED EAKAETIRNL RKSFASLFSD
//
